Posted in:News Samsung Bioepsis, Biogen, and Fujifilm Invalidate Humira® Patents in UK By C. Nichole Gifford March 9, 2017 Comments are off Samsung Bioepsis UK Limited (“Samsung”), Biogen Idec Limited (“Biogen”), and Fujifilm Kyowa Kirin Biologic Company Limited... Read more Tagged with: AbbVie, adalimumab, Biogen, Fujifilm Biologics, Humira®, Invalidity, Legal, Litigation, News, Samsung Bioepsis http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus